Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tally Levy

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Harefuah|April 7, 2004
[Papanicolau smears: reducing the false negative rate by improving the method]Galya Biran, Tally Levy
American Journal of Obstetrics and Gynecology|April 22, 2006
Endometrial endometrioid carcinoma: a glimpse at the natural courseTally Levy, Abraham Golan, Joseph Menczer
Archives of Gynecology and Obstetrics|December 20, 2014
Very late recurrence (after more than 20 years) of epithelial ovarian carcinoma: case report and literature reviewJoseph Menczer, Letizia Schreiber, Ofri Peled, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 30, 2015
The Effect of Cyclooxygenase-2 Expression in Uterine Carcinosarcoma on Survival: A Reassessment Based on Mature DataJoseph Menczer, Letizia Schreiber, Esther Berger, et al.
Journal of Lower Genital Tract Disease|July 4, 2008
Risk factor proportions in Israeli patients with cervical intraepithelial neoplasia 3 and invasive squamous cell carcinomaJoseph Menczer, Erez Ben-Shem, Abraham Golan, et al.
Rambam Maimonides Medical Journal|February 27, 2015
The Significance of Normal Pretreatment Levels of CA125 (<35 U/mL) in Epithelial Ovarian CarcinomaJoseph Menczer, Erez Ben-Shem, Abraham Golan, et al.
Gynecologic Oncology|March 28, 2006
Follow-up of ovarian and primary peritoneal carcinoma: the value of physical examination in patients with pretreatment elevated CA125 levelsJoseph Menczer, Angela Chetrit, Siegal Sadetzki, et al.
Gynecologic Oncology|November 28, 2006
Assessment of Her-2/neu expression in hydatidiform moles for prediction of subsequent gestational trophoblastic neoplasiaJoseph Menczer, Letizia Schreiber, Esther Berger, et al.
BMC Neurology|September 4, 2020
Posterior reversible encephalopathy syndrome case report in an untreated, normotensive, ovarian cancer patient in the presence of paraneoplastic antibodiesElad Barber, Rijini Nugzar, Vitaly Finkelshtein, et al.
International Urogynecology Journal|December 11, 2025
Laparoscopic Management of Intra-Abdominal Bleeding Following Vaginal Hysterectomy, Bilateral Salpingo-Oophorectomy and Pelvic Organ Prolapse SurgeryMatan Friedman, Tally Levy, Masha Ben-Zvi, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Harefuah|April 7, 2004
[Papanicolau smears: reducing the false negative rate by improving the method]Galya Biran, Tally Levy
American Journal of Obstetrics and Gynecology|April 22, 2006
Endometrial endometrioid carcinoma: a glimpse at the natural courseTally Levy, Abraham Golan, Joseph Menczer
Archives of Gynecology and Obstetrics|December 20, 2014
Very late recurrence (after more than 20 years) of epithelial ovarian carcinoma: case report and literature reviewJoseph Menczer, Letizia Schreiber, Ofri Peled, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 30, 2015
The Effect of Cyclooxygenase-2 Expression in Uterine Carcinosarcoma on Survival: A Reassessment Based on Mature DataJoseph Menczer, Letizia Schreiber, Esther Berger, et al.
Journal of Lower Genital Tract Disease|July 4, 2008
Risk factor proportions in Israeli patients with cervical intraepithelial neoplasia 3 and invasive squamous cell carcinomaJoseph Menczer, Erez Ben-Shem, Abraham Golan, et al.
Rambam Maimonides Medical Journal|February 27, 2015
The Significance of Normal Pretreatment Levels of CA125 (<35 U/mL) in Epithelial Ovarian CarcinomaJoseph Menczer, Erez Ben-Shem, Abraham Golan, et al.
Gynecologic Oncology|March 28, 2006
Follow-up of ovarian and primary peritoneal carcinoma: the value of physical examination in patients with pretreatment elevated CA125 levelsJoseph Menczer, Angela Chetrit, Siegal Sadetzki, et al.
Gynecologic Oncology|November 28, 2006
Assessment of Her-2/neu expression in hydatidiform moles for prediction of subsequent gestational trophoblastic neoplasiaJoseph Menczer, Letizia Schreiber, Esther Berger, et al.
BMC Neurology|September 4, 2020
Posterior reversible encephalopathy syndrome case report in an untreated, normotensive, ovarian cancer patient in the presence of paraneoplastic antibodiesElad Barber, Rijini Nugzar, Vitaly Finkelshtein, et al.
International Urogynecology Journal|December 11, 2025
Laparoscopic Management of Intra-Abdominal Bleeding Following Vaginal Hysterectomy, Bilateral Salpingo-Oophorectomy and Pelvic Organ Prolapse SurgeryMatan Friedman, Tally Levy, Masha Ben-Zvi, et al.
Pageof 7